講師
Name /Guzip Biomarkers Corporation
Address /4F., No. 66, Shengyi 5th Rd., Zhubei City, Hsinchu County 302041, Taiwan (R.O.C.)
Name /Polly Lin
Title /CEO
Email /pollylin@guzipbio.com
Telephone /+886-3-578-1168 #30108
Fax /+886-3-578-5099
Mobile /0910390169
Biotechnology
Guzip Biomarkers Corporation (Guzip), a Taiwan startup established in 2018, is specialized at providing novel DNA methylation epigenetic biomarkers for applications in the clinic. Our company vision is to create a better and healthier day for woman and girls, providing accurate, affordable, and safe medical solutions to women.
MPapⓇ test
Our first product, MPapⓇ test, is an innovative molecular diagnostic test that can be used for endometrial cancer.
The MPapⓇ test as an auxiliary test for Endometrial Cancer qualitatively detects the methylation status of BHLHE22 and CDO1 genes with Methylation-Specific qPCR (MSP) technology. The test results provide doctors a reference to evaluate how susceptible a woman with abnormal uterine bleeding (AUB), aged >40 or postmenopausal, is to EC, for the justification of whether an invasive endometrial diagnostic procedure (IVP) or conservative treatment to proceed.
Other product pipeline
Guzip also develops the methylation biomarkers for upper urinary tract urothelial carcinoma (UTUC), and predicting biomarkers for the endometrial receptivity during in vitro fertilization (IVF) process.